Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jul 17, 2023
Date Accepted: Oct 20, 2023

The final, peer-reviewed published version of this preprint can be found here:

Self-Reported Medication Use Across Racial and Rural or Urban Subgroups of People Who Are Pregnant in the United States: Decentralized App-Based Cohort Study

Ajayi T, Pawelek J, Bhargava H, Faksh A, Radin J

Self-Reported Medication Use Across Racial and Rural or Urban Subgroups of People Who Are Pregnant in the United States: Decentralized App-Based Cohort Study

JMIR Form Res 2023;7:e50867

DOI: 10.2196/50867

PMID: 38015604

PMCID: 10716764

Self-reported Medication Utilization Across Racial and Rural/Urban Sub-groups of Pregnant People in the U.S.: A Decentralized App-Based Cohort Study

  • Toluwalase Ajayi; 
  • Jeff Pawelek; 
  • Hansa Bhargava; 
  • Arij Faksh; 
  • Jennifer Radin

ABSTRACT

Background:

Maternal health outcomes have been under-researched due to pregnant people being underrepresented or excluded from studies based on their status as a vulnerable population. Medication use, safety, dosing, and efficacy have been particularly understudied in pregnant people, even though it has been shown up to 95% of pregnant people take medications. Utilization of medications and prenatal vitamins across under-represented pregnant populations is not well understood, particulary for communities that are underrepresented in biomedical research (UBR).

Objective:

We aimed to characterize and compare the use of prenatal vitamins, and commonly used over the counter and prescription medications, among pregnant people self-identifying as Black versus non-Black and those living in rural versus urban regions in the United States.

Methods:

We conducted a prospective, decentralized study of 4,130 pregnant study participants who answered survey questionnaires using a mobile research app. All pregnant people living in the U.S. comfortable with reading and writing in English were eligible. The study was conducted in a decentralized fashion with the use of a study app to facilitate enrollment using an eConsent and self-reported data collection.

Results:

Among the study population, there was significantly different utilization of prenatal vitamins, antiemetics, antidepressants, and pain medication across different UBR sub-populations. Black participants reported significantly lower frequencies of prenatal vitamin use compared to non-Black participants (p<0.0001). The frequency of participants who were currently receiving treatment for anxiety and depression also differed by both racial and rural/urban sub-groups. There was significantly lower use of antidepressants (p=0.002) and antiemetics (p=0.02) among Black compared to non-Black participants.

Conclusions:

A prospective decentralized study demonstrated lower use of prenatal vitamins among Black, non-White, and rural pregnant participants and lower use of anti-emetics among Black pregnant participants. Additional research dedicated to identifying how and why these utilization disparities exist can help improve maternal health outcomes, specifically for diverse communities. Clinical Trial: NCT03085875


 Citation

Please cite as:

Ajayi T, Pawelek J, Bhargava H, Faksh A, Radin J

Self-Reported Medication Use Across Racial and Rural or Urban Subgroups of People Who Are Pregnant in the United States: Decentralized App-Based Cohort Study

JMIR Form Res 2023;7:e50867

DOI: 10.2196/50867

PMID: 38015604

PMCID: 10716764

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.